|
| |
 |
 |
 |
 |
| |
|
|
| |
| Members in the News - February 2012 |
| |
 |
| |
Date: February 14, 2012
Subject: Member in the News: Walter Ogier, Acetylon, receives $15m investment from Celgene Corp |
| |
| Walter Ogier, CEO of Acetylon Pharmaceuticals, announced that Celgene Corporation is making a $15M investment in his company via the purchase of Series B-2 Preferred Stock. |
| |
| Read More |
| |
|
| |
Date: February 17, 2012
Subject: Member in the News: Kollol Pal, Mnemosyne, land $5.4 M in Series A round |
| |
| Kollol Pal, founder of Mnemosyne Pharmaceuticals, has landed $5.4 million in a Series A funding round, led by Access BridgeGap Ventures of Cambridge with participation from Slater Technology Fund, the official Rhode Island tech investing arm. |
| |
| Read More |
| |
|
| |
Date: February 20, 2012
Subject: Members in the News: Leslie Williams and Laurie Halloran on MHT BioForum Panel |
| |
| CEO Roundtable members Leslie Williams, CEO of ImmunsanT, Inc., and Laurie Halloran, CEO of Halloran Consulting Group, joined Bruce Booth of Atlas Ventures and Paul Kim of Foley Hoag LLP on the MHT BioForum on Thursday, February 16, to discuss how to continue new drug discovery efforts in this economic and regulatory environment. |
| |
| Read More |
| |
|
| |
|
|
|
